CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Nivagen Pharmaceuticals LLC v. Sun Pharmaceuticals Industries, Inc.

3:25-cv-15210

Overview

Case Number 3:25-cv-15210
Filing Date 2025-09-03
Status Litigation filed
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:1331 Fed. Question
Jury Demand Both

Parties

Defendant

Sun Pharmaceutical Medicare Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

SUN PHARMA ADVANCED RESEARCH COMPANY, LTD. Operating Company

Represented By

1 Attorneys Listed

GREGORY D. MILLER

RIVKIN RADLER LLP

Tel: +1 (201) 287-2460
Fax: +1 (201) 489-0495

25 MAIN STREET, SUITE 501, COURT PLAZA NORTH

SUN PHARMACEUTICAL INDUSTRIES LTD Operating Company

Represented By

0 Attorneys Listed
No attorneys available

SUN PHARMACEUTICALS INDUSTRIES, INC. Operating Company

Represented By

3 Attorneys Listed

TIMOTHY P. GONZALEZ

RIVKIN RADLER, LLP

Tel: +1 (201) 287-2460

NEW JERSEY, 25 MAIN STREET, COURT PLAZA NORTH, SUITE 501

CATHERINE SALERNO

RIVKIN RADLER LLP

Tel: +1 (201) 809-6031

25 MAIN STREET, COURT PLAZA NORTH

GREGORY D. MILLER

RIVKIN RADLER LLP

Tel: +1 (201) 287-2460
Fax: +1 (201) 489-0495

25 MAIN STREET, SUITE 501, COURT PLAZA NORTH

Plaintiff

NIVAGEN PHARMACEUTICALS LLC Operating Company

Represented By

8 Attorneys Listed

ZACHARY R. CIMRING

MCCARTER & ENGLISH, LLP

Tel: +1 (908) 380-7546
Fax: +1 (973) 624-7070

FOUR GATEWAY CENTER, 100 MULBERRY STREET

YIXIN H. TANG

UPADHYE TANG, LLP

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 109 SYMONDS DRIVE, #174

SHASHANK UPADHYE

UPADHYE TANG, LLP

Tel: +1 (312) 327-3326

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 109 SYMONDS DRIVE, #174

CHRISTOPHER BRUNO

UPADHYE TANG, LLP

Tel: +1 (312) 598-2613

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 109 SYMONDS DRIVE, # 174

BRENT BATZER

UPADHYE TANG, LLP

Tel: +1 (312) 598-2612

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 109 SYMONDS DRIVE, #174

BENJAMIN KLEIN

McCarter & English, LLP

Tel: +1 (201) 213-6606

Four Gateway Center, 100 Mulberry St.

MARK M. MAKHAIL

MCCARTER & ENGLISH, LLP

Tel: +1 (973) 639-2092

4 GATEWAY CENTER, 100 MULBERRY ST.

JOSE LUIS LINARES

MCCARTER & ENGLISH, LLP

Tel: +1 (973) 639-7944

FOUR GATEWAY CENTER, 100 MULBERRY STREET

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2025-04-22
IPR2025-00893

Sun Pharmaceutical Industries, Inc. v. Nivagen Pharmaceuticals, Inc.

U.S. Continuation Sibling (11878076)
Status: Discretionary Denial
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11406598
Lyophilized compositions of phenobarbital sodium salt
Filed: 2020-09-18
Issued: 2022-08-09
Active (13.8 yrs remaining)
Expires: 2040-09-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

38

Dispositive

10

Granted

9

Denied

0

Pending / Review

25

Motions by Category

Motion to Dismiss 10 Claim Construction / Markman Filing 13 Motion to Compel Discovery 7 Procedural / Extension Motion 6 Motion to Stay 2

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
NOTICE Defendant Sun Pharmaceutical Industries, Inc.'s Notice Regarding Pending Motion to Dismiss (Dkt. 16) by Sun Pharmaceuticals Industries, Inc. re 16 OPPOSE...
Entry #61 • 2025-06-18 Document →
Motion to Dismiss Pending / Under Review
SEALED SUR-REPLY to Reply to Response to Motion re 16 OPPOSED SEALED MOTION Defendants' Motion to Dismiss for Improper Venue or, in the Alternative, Transfer fi...
Entry #30 • 2024-07-26 Document →
Motion to Dismiss Granted
ORDER granting 25 Motion to Seal Defendant Sun Pharmaceutical Industries, Inc.'s Unopposed Motion for Leave to File Reply in Support of its Motion to Dismiss fo...
Entry #27 • 2024-07-22 Document →
Motion to Dismiss Granted
UNOPPOSED MOTION to Seal Defendant Sun Pharmaceutical Industries, Inc.'s Unopposed Motion for Leave to File Reply in Support of its Motion to Dismiss for Improp...
Entry #25 • 2024-07-19 Document →
Motion to Dismiss Pending / Under Review
SEALED REPLY to Response to Motion re 16 OPPOSED SEALED MOTION Defendants' Motion to Dismiss for Improper Venue or, in the Alternative, Transfer filed by Sun Ph...
Entry #26 • 2024-07-19 Document →
Motion to Dismiss Pending / Under Review
SEALED RESPONSE to Motion re 16 OPPOSED SEALED MOTION Defendants' Motion to Dismiss for Improper Venue or, in the Alternative, Transfer filed by Nivagen, Inc.. ...
Entry #21 • 2024-07-11 Document →

Docket Entries

(280 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT OF U.S. PATENTS: 11,406,598 and 11,878,076 against Sun Pharma Advanced Research Company Ltd., Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Medicare Ltd., Sun Pharmaceuticals Industries, Inc. ( Filing fee $ 405 receipt number ATXEDC-9934190.), filed by Nivagen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(Smith, Melissa) (Entered: 01/23/2024)

Entry #1 • 2024-01-23
1

Fed. R. Civ. P. 7.1(a)(1) Disclosure Statement filed by Nivagen, Inc. (Smith, Melissa) (Entered: 01/23/2024)

Entry #2 • 2024-01-23
1

DEMAND for Trial by Jury by Nivagen, Inc.. (Smith, Melissa) (Entered: 01/23/2024)

Entry #3 • 2024-01-23
1

Notice of Filing of Patent/Trademark Form (AO 120). AO 120 mailed to the Director of the U.S. Patent and Trademark Office. (Smith, Melissa) (Entered: 01/23/2024)

Entry #4 • 2024-01-23
1

NOTICE of Attorney Appearance - Pro Hac Vice by Yixin H Tang on behalf of Nivagen, Inc.. Filing fee $ 100, receipt number ATXEDC-9934823. (Tang, Yixin) (Entered: 01/23/2024)

Entry #5 • 2024-01-23
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc